Cargando…

Use of TYK2 inhibitor to relieve reactive granulomatous dermatitis due to myelodysplastic syndrome

Detalles Bibliográficos
Autores principales: Huang, Christina, Berghoff, Adar, Arbiser, Jack L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493234/
https://www.ncbi.nlm.nih.gov/pubmed/37701885
http://dx.doi.org/10.1016/j.jdcr.2023.08.009
_version_ 1785104430389002240
author Huang, Christina
Berghoff, Adar
Arbiser, Jack L.
author_facet Huang, Christina
Berghoff, Adar
Arbiser, Jack L.
author_sort Huang, Christina
collection PubMed
description
format Online
Article
Text
id pubmed-10493234
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104932342023-09-12 Use of TYK2 inhibitor to relieve reactive granulomatous dermatitis due to myelodysplastic syndrome Huang, Christina Berghoff, Adar Arbiser, Jack L. JAAD Case Rep Case Report Elsevier 2023-08-19 /pmc/articles/PMC10493234/ /pubmed/37701885 http://dx.doi.org/10.1016/j.jdcr.2023.08.009 Text en © 2023 by the American Academy of Dermatology, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Huang, Christina
Berghoff, Adar
Arbiser, Jack L.
Use of TYK2 inhibitor to relieve reactive granulomatous dermatitis due to myelodysplastic syndrome
title Use of TYK2 inhibitor to relieve reactive granulomatous dermatitis due to myelodysplastic syndrome
title_full Use of TYK2 inhibitor to relieve reactive granulomatous dermatitis due to myelodysplastic syndrome
title_fullStr Use of TYK2 inhibitor to relieve reactive granulomatous dermatitis due to myelodysplastic syndrome
title_full_unstemmed Use of TYK2 inhibitor to relieve reactive granulomatous dermatitis due to myelodysplastic syndrome
title_short Use of TYK2 inhibitor to relieve reactive granulomatous dermatitis due to myelodysplastic syndrome
title_sort use of tyk2 inhibitor to relieve reactive granulomatous dermatitis due to myelodysplastic syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493234/
https://www.ncbi.nlm.nih.gov/pubmed/37701885
http://dx.doi.org/10.1016/j.jdcr.2023.08.009
work_keys_str_mv AT huangchristina useoftyk2inhibitortorelievereactivegranulomatousdermatitisduetomyelodysplasticsyndrome
AT berghoffadar useoftyk2inhibitortorelievereactivegranulomatousdermatitisduetomyelodysplasticsyndrome
AT arbiserjackl useoftyk2inhibitortorelievereactivegranulomatousdermatitisduetomyelodysplasticsyndrome